AI identifies early risk patterns for skin cancer

A massive Swedish study shows that AI can spot people at higher risk of melanoma using routine health data. Advanced models significantly outperformed basic methods, identifying high-risk groups with striking accuracy. Some individuals flagged by the system had up to a 33% chance of developing melanoma within five years. This approach could pave the way for smarter, more targeted screening.

from Top Health News -- ScienceDaily https://ift.tt/AH6skmr

This simple change stops robot swarms from getting stuck

In crowded environments, more robots don’t always mean faster results—in fact, too many can bring everything to a standstill. Harvard researchers discovered a surprising fix: adding a bit of randomness to how robots move can actually prevent gridlock and boost efficiency. By allowing robots to “wiggle” slightly instead of marching in straight lines, they can slip past each other and keep tasks flowing smoothly.

from Latest Science News -- ScienceDaily https://ift.tt/G7cWftQ

This common gout drug may slash heart attack and stroke risk

A major new study reveals that treating gout may do far more than ease painful joint flare-ups—it could also protect the heart. Researchers found that patients who took common gout medications like allopurinol and successfully lowered their blood urate levels had a significantly reduced risk of heart attacks, strokes, and cardiovascular death over five years.

from Top Health News -- ScienceDaily https://ift.tt/2ebTMr3

The people you live with could be changing your gut bacteria

Spending time with close companions might do more than strengthen bonds—it could also reshape your gut bacteria. In a study of island birds, those with stronger social ties shared more gut microbes, especially types that require direct contact to spread. This suggests that social interaction itself—not just shared space—drives microbial exchange. The same process may be happening in human households through everyday closeness.

from Top Health News -- ScienceDaily https://ift.tt/uyjPOik

Forget daily pills. This shot works when blood pressure meds fail

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.

from Latest Science News -- ScienceDaily https://ift.tt/fKcsI72

Forget daily pills. This shot works when blood pressure meds fail

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.

from Top Health News -- ScienceDaily https://ift.tt/fKcsI72

Hidden weak spots in HIV and Ebola revealed with breakthrough nanodisc technology

A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines.

from Top Health News -- ScienceDaily https://ift.tt/MunC962